ABEONA THERAPEUT. DL-01
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt dise… Read more
Market Cap & Net Worth: ABEONA THERAPEUT. DL-01 (PCJ)
ABEONA THERAPEUT. DL-01 (F:PCJ) has a market capitalization of $234.74 Million (€228.69 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #15647 globally and #1608 in its home market, demonstrating a 2.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ABEONA THERAPEUT. DL-01's stock price €4.22 by its total outstanding shares 54191361 (54.19 Million).
ABEONA THERAPEUT. DL-01 Market Cap History: 2015 to 2026
ABEONA THERAPEUT. DL-01's market capitalization history from 2015 to 2026. Data shows growth from $175.72 Million to $234.74 Million (1.59% CAGR).
ABEONA THERAPEUT. DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ABEONA THERAPEUT. DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PCJ by Market Capitalization
Companies near ABEONA THERAPEUT. DL-01 in the global market cap rankings as of March 19, 2026.
Key companies related to ABEONA THERAPEUT. DL-01 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ABEONA THERAPEUT. DL-01 Historical Marketcap From 2015 to 2026
Between 2015 and today, ABEONA THERAPEUT. DL-01's market cap moved from $175.72 Million to $ 234.74 Million, with a yearly change of 1.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €234.74 Million | -9.44% |
| 2025 | €259.22 Million | -11.24% |
| 2024 | €292.04 Million | +15.89% |
| 2023 | €251.99 Million | +75.58% |
| 2022 | €143.51 Million | +891.54% |
| 2021 | €14.47 Million | -78.84% |
| 2020 | €68.39 Million | -59.02% |
| 2019 | €166.88 Million | -47.28% |
| 2018 | €316.51 Million | -57.30% |
| 2017 | €741.16 Million | +190.98% |
| 2016 | €254.71 Million | +44.95% |
| 2015 | €175.72 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ABEONA THERAPEUT. DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $234.74 Million USD |
| MoneyControl | $234.74 Million USD |
| MarketWatch | $234.74 Million USD |
| marketcap.company | $234.74 Million USD |
| Reuters | $234.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.